News

Arrhythmia Alliance Pace4Life (A-A P4L) is celebrating the release of study results from our partner, The University of Michigan’s My Heart Your Heart (MHYH) program.

BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve...

The approval will provide patients in the U.S. with a new treatment option and is an important step for AOP Health in bringing its mission to help patients and make an impact on rare diseases and critical care to the United States for the...

Heart Failure Society of America Press Release  WASHINGTON, Nov. 26, 2024 -- Patients with heart failure (HF) suffer from compromised quality of life, high mortality, and complex medical decision-making. Palliative care is...

Tenaya Therapeutics Press Release  SOUTH SAN FRANCISCO, Calif., Nov. 25, 2024 -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially...

PaceMate Press Release  SARASOTA, Fla. -- A newly published study in Heart Rhythm reveals how artificial intelligence (AI) algorithms embedded in Medtronic’s LINQ II implantable loop recorders (ILRs) dramatically reduce...

Korea University College of Medicine Press Release SEOUL, South Korea, Nov. 15, 2024 -- Development of coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute respiratory syndrome...

Intermountain Health Press Release  A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac...

TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product, TAH3311, an innovative antithrombotic oral dissolving film (ODF).

HeartBeam Press Release SANTA CLARA, Calif. -- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announced the results...